Upstream Bio (UPB) EBT Margin (2023 - 2025)
Historic EBT Margin for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to 4938.36%.
- Upstream Bio's EBT Margin fell 23042600.0% to 4938.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 4364.31%, marking a year-over-year decrease of 17721000.0%. This contributed to the annual value of 2769.66% for FY2024, which is 12592000.0% down from last year.
- Per Upstream Bio's latest filing, its EBT Margin stood at 4938.36% for Q3 2025, which was down 23042600.0% from 4259.98% recorded in Q2 2025.
- In the past 5 years, Upstream Bio's EBT Margin registered a high of 1265.54% during Q3 2023, and its lowest value of 4938.36% during Q3 2025.
- Over the past 3 years, Upstream Bio's median EBT Margin value was 2875.1% (recorded in 2024), while the average stood at 3250.13%.
- Its EBT Margin has fluctuated over the past 5 years, first plummeted by -6183600bps in 2024, then plummeted by -26700500bps in 2025.
- Quarter analysis of 3 years shows Upstream Bio's EBT Margin stood at 2846.89% in 2023, then decreased by -22bps to 3465.25% in 2024, then tumbled by -43bps to 4938.36% in 2025.
- Its EBT Margin stands at 4938.36% for Q3 2025, versus 4259.98% for Q2 2025 and 4818.02% for Q1 2025.